SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Target Corp. – ‘10-K’ for 1/30/21 – ‘EX-4.D’

On:  Wednesday, 3/10/21, at 2:49pm ET   ·   For:  1/30/21   ·   Accession #:  27419-21-10   ·   File #:  1-06049

Previous ‘10-K’:  ‘10-K’ on 3/11/20 for 2/1/20   ·   Next:  ‘10-K’ on 3/9/22 for 1/29/22   ·   Latest:  ‘10-K’ on 3/13/24 for 2/3/24   ·   43 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/10/21  Target Corp.                      10-K        1/30/21  130:12M

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.26M 
 2: EX-4.D      Instrument Defining the Rights of Security Holders  HTML     42K 
 3: EX-10.A     Material Contract                                   HTML     47K 
 4: EX-10.J     Material Contract                                   HTML    201K 
 5: EX-10.S     Material Contract                                   HTML     39K 
 6: EX-10.U     Material Contract                                   HTML     60K 
 7: EX-10.V     Material Contract                                   HTML     61K 
 8: EX-10.W     Material Contract                                   HTML     61K 
 9: EX-21       Subsidiaries List                                   HTML     31K 
10: EX-23       Consent of Expert or Counsel                        HTML     35K 
11: EX-24       Power of Attorney                                   HTML     70K 
12: EX-31.A     Certification -- §302 - SOA'02                      HTML     36K 
13: EX-31.B     Certification -- §302 - SOA'02                      HTML     36K 
14: EX-32.A     Certification -- §906 - SOA'02                      HTML     33K 
15: EX-32.B     Certification -- §906 - SOA'02                      HTML     33K 
22: R1          Cover Page                                          HTML     95K 
23: R2          Consolidated Statements of Operations               HTML    118K 
24: R3          Consolidated Statements of Comprehensive Income     HTML     51K 
25: R4          Consolidated Statements of Financial Position       HTML    118K 
26: R5          Consolidated Statements of Financial Position       HTML     48K 
                (Parenthetical)                                                  
27: R6          Consolidated Statements of Cash Flows               HTML    123K 
28: R7          Consolidated Statements of Shareholders'            HTML     77K 
                Investment                                                       
29: R8          Consolidated Statements of Shareholders'            HTML     33K 
                Investment (Parenthetical)                                       
30: R9          Summary of Accounting Policies                      HTML     38K 
31: R10         Coronavirus (Covid-19)                              HTML     35K 
32: R11         Revenues                                            HTML     70K 
33: R12         Cost of Sales and Selling, General and              HTML     38K 
                Administrative Expenses                                          
34: R13         Consideration Received from Vendors                 HTML     35K 
35: R14         Advertising Costs                                   HTML     34K 
36: R15         Fair Value Measurements                             HTML     58K 
37: R16         Cash and Cash Equivalents                           HTML     42K 
38: R17         Inventory                                           HTML     34K 
39: R18         Other Current Assets                                HTML     39K 
40: R19         Property and Equipment                              HTML     38K 
41: R20         Other Noncurrent Assets                             HTML     38K 
42: R21         Goodwill and Intangible Assets                      HTML     34K 
43: R22         Accrued and Other Current Liabilities               HTML     45K 
44: R23         Commitments and Contingencies                       HTML     38K 
45: R24         Commercial Paper and Long-Term Debt                 HTML     64K 
46: R25         Derivative Financial Instruments                    HTML     47K 
47: R26         Leases                                              HTML    157K 
48: R27         Income Taxes                                        HTML     95K 
49: R28         Other Noncurrent Liabilities                        HTML     42K 
50: R29         Share Repurchase                                    HTML     40K 
51: R30         Share-Based Compensation                            HTML     80K 
52: R31         Defined Contribution Plans                          HTML     46K 
53: R32         Pension Plans                                       HTML    156K 
54: R33         Accumulated Other Comprehensive Loss                HTML     48K 
55: R34         Summary of Accounting Policies (Policies)           HTML    110K 
56: R35         Revenues (Tables)                                   HTML     64K 
57: R36         Fair Value Measurements (Tables)                    HTML     60K 
58: R37         Cash and Cash Equivalents (Tables)                  HTML     40K 
59: R38         Other Current Assets (Tables)                       HTML     39K 
60: R39         Property and Equipment (Tables)                     HTML     35K 
61: R40         Other Noncurrent Assets (Tables)                    HTML     39K 
62: R41         Accrued and Other Current Liabilities (Tables)      HTML     45K 
63: R42         Commercial Paper and Long-Term Debt (Tables)        HTML     68K 
64: R43         Derivative Financial Instruments (Tables)           HTML     45K 
65: R44         Leases (Tables)                                     HTML    113K 
66: R45         Income Taxes (Tables)                               HTML     97K 
67: R46         Other Noncurrent Liabilities (Tables)               HTML     42K 
68: R47         Share Repurchase (Tables)                           HTML     40K 
69: R48         Share-Based Compensation (Tables)                   HTML     79K 
70: R49         Defined Contribution Plans (Tables)                 HTML     43K 
71: R50         Pension Plans (Tables)                              HTML    163K 
72: R51         Accumulated Other Comprehensive Loss (Tables)       HTML     48K 
73: R52         Coronavirus (Covid-19) (Details)                    HTML     40K 
74: R53         Revenues - Disaggregation of Revenue (Details)      HTML     58K 
75: R54         Revenues - Narrative (Details)                      HTML     49K 
76: R55         Revenues - Gift Card Liability Activity (Details)   HTML     37K 
77: R56         Advertising Costs (Details)                         HTML     33K 
78: R57         Fair Value Measurements - Schedule of Fair Value    HTML     49K 
                Measurements - Recurring Basis (Details)                         
79: R58         Fair Value Measurements - Schedule of Significant   HTML     37K 
                Financial Instruments not Measured at Fair Value                 
                (Details)                                                        
80: R59         Fair Value Measurements - Narrative (Details)       HTML     35K 
81: R60         Cash and Cash Equivalents - Narrative (Details)     HTML     40K 
82: R61         Cash and Cash Equivalents - Schedule of Cash and    HTML     42K 
                Cash Equivalents (Details)                                       
83: R62         Other Current Assets (Details)                      HTML     41K 
84: R63         Property and Equipment (Details)                    HTML     51K 
85: R64         Other Noncurrent Assets (Details)                   HTML     39K 
86: R65         Goodwill and Intangible Assets - Goodwill           HTML     37K 
                (Details)                                                        
87: R66         Goodwill and Intangible Assets - Intangible Assets  HTML     60K 
                (Details)                                                        
88: R67         Accrued and Other Current Liabilities (Details)     HTML     55K 
89: R68         Commitments and Contingencies (Details)             HTML     47K 
90: R69         Commercial Paper and Long-Term Debt - Schedule of   HTML     59K 
                Carrying Value and Maturities of Debt Portfolio                  
                (Details)                                                        
91: R70         Commercial Paper and Long-Term Debt - Schedule of   HTML     44K 
                Required Principal Payments (Details)                            
92: R71         Commercial Paper and Long-Term Debt - Narrative     HTML     76K 
                (Details)                                                        
93: R72         Commercial Paper and Long-Term Debt - Schedule of   HTML     41K 
                Commercial Paper (Details)                                       
94: R73         Derivative Financial Instruments - Narrative        HTML     45K 
                (Details)                                                        
95: R74         Derivative Financial Instruments - Effect of        HTML     37K 
                Hedges On Debt (Details)                                         
96: R75         Derivative Financial Instruments - Effect of        HTML     38K 
                Hedges on Net Interest Expense (Details)                         
97: R76         Leases - Narrative (Details)                        HTML     39K 
98: R77         Leases - Lease Assets and Liabilities (Details)     HTML     62K 
99: R78         Leases - Lease Cost (Details)                       HTML     47K 
100: R79         Leases - Maturity of Lease Liabilities (Details)    HTML     92K  
101: R80         Leases - Lease Term and Discount Rate (Details)     HTML     42K  
102: R81         Leases - Other Information (Details)                HTML     38K  
103: R82         Income Taxes - Narrative (Details)                  HTML     47K  
104: R83         Income Taxes - Schedule of Tax Rate Reconciliation  HTML     52K  
                - Continuing Operations (Details)                                
105: R84         Income Taxes - Schedule of Provision for Income     HTML     59K  
                Taxes (Details)                                                  
106: R85         Income Taxes - Schedule of Net Deferred Tax         HTML     63K  
                Asset/(Liability) (Details)                                      
107: R86         Income Taxes - Schedule of Reconciliation of        HTML     43K  
                Liability for Unrecognized Tax Benefits (Details)                
108: R87         Other Noncurrent Liabilities (Details)              HTML     48K  
109: R88         Share Repurchase (Details)                          HTML     38K  
110: R89         Share-Based Compensation - Narrative (Details)      HTML     74K  
111: R90         Share-Based Compensation - Schedule of Restricted   HTML     66K  
                Stock Activity and Performance Share Unit Activity               
                (Details)                                                        
112: R91         Share-Based Compensation - Schedule of Stock        HTML     63K  
                Option Activity (Details)                                        
113: R92         Share-Based Compensation - Schedule of Stock        HTML     38K  
                Option Exercises (Details)                                       
114: R93         Defined Contribution Plans (Details)                HTML     55K  
115: R94         Pension Plans - Schedule of Recognition of          HTML     45K  
                Funded/(Underfunded) Status (Details)                            
116: R95         Pension Plans - Schedule of Estimated Future        HTML     44K  
                Benefit Payments (Details)                                       
117: R96         Pension Plans - Schedule of Net Pension Benefit     HTML     53K  
                Expense (Details)                                                
118: R97         Pension Plans - Schedule of Benefit Obligation      HTML     38K  
                Weighted Average Assumptions (Details)                           
119: R98         Pension Plans - Schedule of Net Periodic Benefit    HTML     41K  
                Expense Weighted Average Assumptions (Details)                   
120: R99         Pension Plans - Narrative (Details)                 HTML     61K  
121: R100        Pension Plans - Schedule of Change in Projected     HTML     55K  
                Benefit Obligation (Details)                                     
122: R101        Pension Plans - Schedule of Change in Plan Assets   HTML     53K  
                (Details)                                                        
123: R102        Pension Plans - Schedule of Asset Category          HTML     53K  
                (Details)                                                        
124: R103        Pension Plans - Schedule of Fair Value              HTML     61K  
                Measurements (Details)                                           
125: R104        Pension Plans - Schedule of Amounts in Accumulated  HTML     42K  
                Other Comprehensive Income (Details)                             
126: R105        Accumulated Other Comprehensive Loss (Details)      HTML     63K  
128: XML         IDEA XML File -- Filing Summary                      XML    227K  
21: XML         XBRL Instance -- tgt-20210130_htm                    XML   2.52M 
127: EXCEL       IDEA Workbook of Financial Reports                  XLSX    129K  
17: EX-101.CAL  XBRL Calculations -- tgt-20210130_cal                XML    360K 
18: EX-101.DEF  XBRL Definitions -- tgt-20210130_def                 XML    625K 
19: EX-101.LAB  XBRL Labels -- tgt-20210130_lab                      XML   2.22M 
20: EX-101.PRE  XBRL Presentations -- tgt-20210130_pre               XML   1.22M 
16: EX-101.SCH  XBRL Schema -- tgt-20210130                          XSD    235K 
129: JSON        XBRL Instance as JSON Data -- MetaLinks              519±   762K  
130: ZIP         XBRL Zipped Folder -- 0000027419-21-000010-xbrl      Zip    659K  


‘EX-4.D’   —   Instrument Defining the Rights of Security Holders


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  
Exhibit (4)D
DESCRIPTION OF THE REGISTRANT’S SECURITIES
REGISTERED PURSUANT TO SECTION 12 OF THE
SECURITIES EXCHANGE ACT OF 1934

The following description summarizes the material terms and provisions of the common stock of Target Corporation, which is our only class of securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended. It is subject to and qualified in its entirety by reference to our amended and restated articles of incorporation, our bylaws and the applicable provisions of the Minnesota Business Corporation Act (“MBCA”) for additional information.

General

Authorized Capital Stock. We are authorized to issue up to 6,000,000,000 shares of common stock, par value $0.0833 per share, and 5,000,000 shares of preferred stock, par value $0.01 per share.

Dividends. Holders of common stock may receive dividends if, when and as declared by our board of directors out of our funds that we can legally use to pay dividends. We may pay dividends in cash, stock or other property. In certain cases, holders of common stock may not receive dividends until we have satisfied our obligations to any holders of outstanding preferred stock.

Voting Rights. Holders of common stock have the exclusive power to vote on all matters presented to our shareholders unless Minnesota law or the certificate of designation for an outstanding series of preferred stock gives the holders of that preferred stock the right to vote on certain matters. Each holder of common stock is entitled to one vote per share. Holders of common stock may not cumulate their votes when voting for directors, which means that a holder cannot cast more than one vote per share for each director.

Other Rights. If we voluntarily or involuntarily liquidate, dissolve or wind up our business, holders of common stock will receive pro rata, according to shares held by them, any remaining assets distributable to our shareholders after we have provided for any liquidation preference for outstanding shares of preferred stock. When we issue securities in the future, holders of common stock have no preemptive rights to buy any portion of those issued securities. Holders of our common stock have no rights to have their shares of common stock redeemed by us or to convert their shares of common stock into shares of any other class of our capital stock.

Listing. Our outstanding shares of common stock are listed on the New York Stock Exchange under the symbol “TGT.” EQ Shareowner Services serves as the transfer agent and registrar for our common stock.

Fully Paid. The outstanding shares of common stock are fully paid and nonassessable. This means the full purchase price for the outstanding shares of common stock has been paid and the holders of such shares will not be assessed any additional amounts for such shares. Any additional common stock that we may issue in the future pursuant to an offering under a prospectus or upon the conversion or exercise of other securities will also be fully paid and nonassessable.

Anti-takeover Provisions Contained in Our Articles of Incorporation and Bylaws

Certain provisions of our amended and restated articles of incorporation and bylaws may make it less likely that our management would be changed or someone would acquire voting control of our company without our board’s consent. These provisions may delay, deter or prevent tender offers or takeover attempts that shareholders may believe are in their best interests, including tender offers or attempts that might allow shareholders to receive premiums over the market price of their common stock.

Preferred Stock. Our board of directors can at any time, under our amended and restated articles of incorporation, and without shareholder approval, issue one or more new series of preferred stock. In some cases, the issuance of preferred stock without shareholder approval could discourage or make more difficult attempts to take control of our company through a merger, tender offer, proxy contest or otherwise. Preferred stock with special voting rights or other features issued to persons favoring our management could stop a takeover by preventing the person trying to take
1


control of our company from acquiring enough voting shares necessary to take control.

Nomination Procedures. In addition to our board of directors, shareholders can nominate candidates for our board of directors. However, a shareholder must follow the advance notice procedures described in Section 2.09 of our bylaws. In general, a shareholder must submit a written notice of the nomination to our corporate secretary at least 90 days before the anniversary date of the prior year’s annual meeting of shareholders, together with required information regarding the shareholder proponent and the nominee and the written consent of the nominee to serve as director. Shareholders seeking to have director nominations included in our annual proxy statement must comply with the requirements of Section 2.10 of our bylaws. Among other things, the shareholder, or group of up to 20 shareholders, must own 3% or more of our outstanding common stock continuously for at least the previous three years to nominate and include in our annual proxy statement director nominees constituting up to 20% of our board of directors or at least two directors.

Proposal Procedures. Shareholders can propose that business other than nominations to our board of directors be considered at an annual meeting of shareholders only if a shareholder follows the advance notice procedures described in our bylaws. In general, a shareholder must submit a written notice of the proposal together with required information regarding the shareholder and the shareholder’s interest in the proposal to our corporate secretary at least 90 days before the anniversary date of the previous year’s annual meeting of our shareholders. Shareholders seeking to have a proposal, other than director nominations, included in our annual proxy statement must comply with the requirements of Rule 14a-8 of the proxy rules under the federal securities laws.

Amendment of Bylaws. Under our bylaws, our board of directors can adopt, amend or repeal the bylaws, subject to limitations under the MBCA. Our shareholders also have the power to change or repeal our bylaws.

Certain Provisions of the MBCA

Shareholder Action by Unanimous Written Consent. Section 302A.441 of the MBCA provides that action may be taken by shareholders without a meeting only by unanimous written consent.

Control Share Provision. Section 302A.671 of the MBCA applies, with certain exceptions, to any acquisition of our voting stock (from a person other than us and other than in connection with certain mergers and exchanges to which we are a party) resulting in the acquiring person owning 20% or more of our voting stock then outstanding. Section 302A.671 requires approval of any such acquisitions by both (i) the affirmative vote of the holders of a majority of the shares entitled to vote, including shares held by the acquiring person, and (ii) the affirmative vote of the holders of a majority of the shares entitled to vote, excluding all interested shares. In general, shares acquired in the absence of such approval are denied voting rights and are redeemable at their then fair market value by us within 30 days after the acquiring person has failed to give a timely information statement to us or the date the shareholders voted not to grant voting rights to the acquiring person’s shares.

Business Combination Provision. Section 302A.673 of the MBCA generally prohibits us or any of our subsidiaries from entering into any merger, share exchange, sale of material assets or similar transaction with a 10% shareholder within four years following the date the person became a 10% shareholder, unless either the transaction or the person’s acquisition of shares is approved prior to the person becoming a 10% shareholder by a committee of all of the disinterested members of our board of directors.

Takeover Offer; Fair Price. Under Section 302A.675 of the MBCA, an offeror may not acquire shares of a publicly held corporation within two years following the last purchase of shares pursuant to a takeover offer with respect to that class, including acquisitions made by purchase, exchange, merger, consolidation, partial or complete liquidation, redemption, reverse stock split, recapitalization, reorganization, or any other similar transaction, unless (i) the acquisition is approved by a committee of the board’s disinterested directors before the purchase of any shares by the offeror pursuant to the earlier takeover offer, or (ii) shareholders are afforded, at the time of the
2


proposed acquisition, a reasonable opportunity to dispose of the shares to the offeror upon substantially equivalent terms as those provided in the earlier takeover offer.

Greenmail Restrictions. Under Section 302A.553 of the MBCA, a corporation is prohibited from buying shares at an above-market price from a greater than 5% shareholder who has held the shares for less than two years unless (i) the purchase is approved by holders of a majority of the outstanding shares entitled to vote, or (ii) the corporation makes an equal or better offer to all shareholders for all other shares of that class or series and any other class or series into which they may be converted.
3

14 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/13/24  Target Corp.                      10-K        2/03/24  131:11M
11/22/23  Target Corp.                      S-3ASR     11/22/23    6:708K                                   Workiva Inc Wde… FA01/FA
 3/08/23  Target Corp.                      10-K        1/28/23  127:12M
 1/18/23  Target Corp.                      424B2                  2:753K                                   Toppan Merrill/FA
 1/17/23  Target Corp.                      424B2                  1:755K                                   Toppan Merrill/FA
 9/07/22  Target Corp.                      424B2                  2:646K                                   Toppan Merrill/FA
 9/06/22  Target Corp.                      424B2                  1:626K                                   Toppan Merrill/FA
 3/09/22  Target Corp.                      10-K        1/29/22  124:11M
 1/20/22  Target Corp.                      424B2                  1:671K                                   Toppan Merrill/FA
 1/19/22  Target Corp.                      424B2                  1:638K                                   Toppan Merrill/FA
11/24/21  Target Corp.                      10-Q       10/30/21   57:5.8M
 8/27/21  Target Corp.                      10-Q        7/31/21   55:4.5M
 5/28/21  Target Corp.                      10-Q        5/01/21   55:3.9M
 3/11/21  Target Corp.                      S-3ASR      3/11/21    6:949K                                   Toppan Merrill/FA


29 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/28/20  Target Corp.                      10-Q        8/01/20   57:5.7M
 6/11/20  Target Corp.                      8-K:5       6/10/20   13:451K
 4/02/20  Target Corp.                      8-K:5,9     3/27/20   11:343K                                   Toppan Merrill/FA
 3/11/20  Target Corp.                      10-K        2/01/20  130:15M
 3/13/19  Target Corp.                      10-K        2/02/19  129:13M
 1/10/19  Target Corp.                      8-K:5,9     1/07/19    2:85K                                    Toppan Merrill/FA
11/27/18  Target Corp.                      10-Q       11/03/18   64:7.7M
 3/14/18  Target Corp.                      10-K        2/03/18  143:12M
11/20/17  Target Corp.                      10-Q       10/28/17   64:4.4M
 8/21/17  Target Corp.                      10-Q        7/29/17   60:4.2M
 5/22/17  Target Corp.                      10-Q        4/29/17   50:3.2M
 3/08/17  Target Corp.                      10-K        1/28/17  147:13M
11/23/16  Target Corp.                      10-Q       10/29/16   66:6.1M
 5/25/16  Target Corp.                      10-Q        4/30/16   66:5.1M
 3/11/16  Target Corp.                      10-K        1/30/16  161:16M
 5/28/15  Target Corp.                      10-Q        5/02/15   63:6.3M
 3/13/15  Target Corp.                      10-K        1/31/15  127:20M
 3/14/14  Target Corp.                      10-K        2/01/14  118:19M
 7/29/13  Target Corp.                      10-Q/A      5/04/13    4:1.1M                                   Toppan Merrill/FA
 3/20/13  Target Corp.                      10-K        2/02/13  124:15M                                    Toppan Merrill-FA
 1/11/12  Target Corp.                      8-K:5,9     1/11/12    6:258K                                   Toppan Merrill/FA
 8/25/11  Target Corp.                      10-Q        7/30/11   69:14M                                    Toppan Merrill/FA
12/03/10  Target Corp.                      10-Q       10/30/10   51:9.7M                                   Toppan Merrill/FA
 6/10/10  Target Corp.                      8-K:5,9     6/09/10    3:121K                                   Toppan Merrill/FA
 3/13/09  Target Corp.                      10-K        1/31/09   18:3.3M                                   Toppan Merrill-FA
 5/01/07  Target Corp.                      8-K:9       5/01/07    4:144K                                   Toppan Merrill/FA
 3/15/07  Target Corp.                      10-K        2/03/07   18:1.6M                                   Toppan Merrill-FA
 4/11/05  Target Corp.                      10-K        1/29/05   13:2.7M                                   Toppan Merrill/FA
 8/10/00  Target Corp.                      8-K:7       8/10/00    2:450K                                   Toppan Merrill-FA2/FA
Top
Filing Submission 0000027419-21-000010   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 26, 10:23:50.3am ET